Dynavax Technologies traded at $12.96 this Friday July 1st, increasing $0.37 or 2.94 percent since the previous trading session. Looking back, over the last four weeks, Dynavax Technologies gained 7.20 percent. Over the last 12 months, its price rose by 30.91 percent. Looking ahead, we forecast Dynavax Technologies to be priced at 12.61 by the end of this quarter and at 11.61 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.80 0.64 0.42% 33.54%
Adma Biologics 2.03 0.05 2.53% 30.97%
Agenus 1.96 0.02 1.03% -64.49%
Amgen 245.55 2.25 0.92% -1.27%
AstraZeneca 10,808.00 54.00 0.50% 24.54%
Astrazeneca 65.95 -0.12 -0.18% 8.49%
Biogen 210.63 6.69 3.28% -39.60%
BioMarin Pharmaceutical 84.98 2.11 2.55% -0.57%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Chimerix 2.14 0.06 2.88% -74.31%
Dynavax Technologies 12.96 0.37 2.94% 30.91%
Gilead Sciences 62.36 0.55 0.89% -10.01%
Glaxosmithkline 43.75 0.22 0.51% 8.27%
Idera Pharmaceuticals 0.44 -0.02 -4.58% -62.56%
Merck & Co 92.42 1.25 1.37% 17.58%
Neurocrine Biosciences 99.25 1.77 1.82% 0.65%
Minerva Neurosciences 3.59 0.28 8.46% 54.74%
Nektar Therapeutics 3.75 -0.05 -1.32% -78.08%
Novartis 81.65 1.32 1.64% -3.02%
Pfizer 52.31 -0.12 -0.23% 31.66%
Regeneron Pharmaceuticals 595.40 4.27 0.72% 2.01%
Roche Holding 322.10 1.70 0.53% -8.06%
Sarepta Therapeutics 75.71 0.75 1.00% 0.62%
TG Therapeutics 4.57 0.32 7.53% -88.61%
Vertex Pharmaceuticals 287.32 5.53 1.96% 43.27%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US2000 1728 19.77 1.16% -25.07%

Dynavax Technologies
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing novel vaccines. The Company's products include HEPLISAV-B and CpG 1018TM. The HEPLISAV-B is for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The Company also manufactures and sells CpG 1018TM, the adjuvant used in HEPLISAV-B. The Company also engaged in developing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships.